Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8701–8750 of 18433
On August 18, 2023, Dan L. Dearen, President and Chief Financial Officer (Principal Financial and Accounting Officer) of Axonics, Inc. (the “Company”), provided formal notice of his decision to retire from the Company effective October 2, 2023.
Effective upon Mr. Dearen’s exit on October 2, 2023, the Company intends to appoint Kari Keese to serve as Chief Financial Officer.
Mr. Alkire will succeed Rustin Welton, who will be transitioning out of his current role of Executive Vice President and Chief Financial Officer effective August 31, 2023, and will serve in an advisory role for a transition period.
On August 21, 2023, the Board of Directors of Kontoor Brands, Inc. (the “Company”) announced Joseph A. Alkire as Executive Vice President and Chief Financial Officer effective August 31, 2023.
On August 17, 2023, the Company appointed Mr. Labrucherie as its full time Chief Financial Officer.
Robert B. Scott will be appointed as Chief Financial Officer of Nuwellis, Inc.
On August 17, 2023, Mr. Michael C. Donegan, the Principal Financial and Accounting Officer of the Company, notified the Company of his decision to resign from such positions, effective as of August 17, 2023.
Mr. Ziegler succeeded Mr. Donegan as Principal Financial and Accounting Officer as of the effective date of Mr. Donegan’s resignation.
On August 12, 2023, Richard Landry resigned from his position as our Chief Financial Officer.
On the same date, the Board appointed Michael Hastings as Chief Financial Officer.
On August 14, 2023, Robert Potashnick notified the Company of his decision to resign as Chief Financial Officer of the Company, effective as of September 13, 2023, to pursue other opportunities.
On August 18, 2023, the Company’s board of directors appointed Ray Chen to serve as Chief Executive Officer and Chief Financial Officer of the Company.
On August 18, 2023, the Company’s board of directors appointed Ray Chen to serve as Chief Executive Officer and Chief Financial Officer of the Company.
On August 18, 2023, Yuquan Wang resigned as Chief Executive Officer of FutureTech II Acquisition Corp.
On August 18, 2023, Michael Greenall resigned as Chief Financial Officer of the Company and as a member of the Company’s board of directors, effective immediately.
On August 18, 2023, Jacob Patterson, Chief Financial Officer of RegenETP, Inc. (formerly known as PolarityTE, Inc.), a Delaware corporation (the “Company”), informed the Company of his decision to resign effective immediately in order to pursue other opportunities.
On August 15, 2023, Scott Burrows notified Arcutis Biotherapeutics, Inc. (the “Company”) of his decision to resign as chief financial officer of the Company, effective as of August 31, 2023.
The Company has commenced a search for a permanent chief financial officer and has appointed John Smither, who previously served as the Company’s chief financial officer from May 2019 until his retirement in March 2021, as interim chief financial officer, effective upon Mr. Burrows’ departure from the Company on August 31, 2023.
Corey Campbell ceased to serve as the Company’s Chief Financial Officer effective as of Mr. Stanfield’s appointment.
On August 11, 2023, Portage Fintech Acquisition Corporation (the “ Company ”) appointed John P. Stanfield to serve as its Chief Financial Officer, effective immediately.
the departure of Shane Torchiana from his position as the Chief Executive Officer of the Company, effective as of August 9, 2023
On August 17, 2023, David L. Goodin, President and Chief Executive Officer of MDU Resources Group, Inc. (the “Company”), informed the Board of Directors (the “Board”) of the Company of his intention to retire as President and Chief Executive Officer effective as of end of day January 5, 2024.
On August 17, 2023, the Board appointed Nicole A. Kivisto to succeed Mr. Goodin as President and Chief Executive Officer, effective as of January 6, 2024.
Effective August 16, 2023, Joel S. Hatlen is retiring as the Company’s Vice President, Chief Financial Officer, Chief Operating Officer, Corporate Secretary and Treasurer.
Effective August 16, 2023, Gerald became the Company’s Vice President, Chief Financial Officer, Corporate Secretary and Treasurer.
on August 8, 2023, the Board of Directors (the “ Board ”) of the Company approved the appointment of Robert C. Daigle to succeed Michael Whang as President and Chief Executive Officer of the Company effective August 8, 2023.
on August 8, 2023, the Board of Directors (the “ Board ”) of the Company approved the appointment of Robert C. Daigle to succeed Michael Whang as President and Chief Executive Officer of the Company effective August 8, 2023.
Dean A. Shigenaga, President and Chief Financial Officer of Alexandria Real Estate Equities, Inc. (the “Company”), submitted his resignation from all of his positions with the Company and its subsidiaries for important personal family health reasons, effective September 15, 2023.
the Board elected Marc E. Binda as Chief Financial Officer and Treasurer, effective September 15, 2023.
Yasir Al-Wakeel, BM BCh, the Chief Financial Officer and Head of Corporate Development, principal financial officer and principal accounting officer of Kronos Bio, Inc. (the "Company"), notified the Company of his decision to resign, effective at the close of business on September 15, 2023, to pursue other opportunities.
Josh Blacher of Danforth, an experienced biotech executive who specializes in strategic finance and corporate development, has been named as the Company’s Interim Chief Financial Officer.
Bob Myers, the Chief Financial Officer, Corporate Secretary and Compliance Officer of Predictive Oncology Inc. (the "Company"), notified the Company of his intent to resign from the Company effective September 30, 2023 (the "Transition Date").
On August 11, 2023, Joe Annoni, Chief Financial Officer and Assistant Chief Restructuring Officer of Athenex, Inc. (the “Company”), and the Company mutually agreed that Mr. Annoni would separate from the Company effective immediately.
John Alam, MD has served as the President and Chief Executive Officer of the Company since August 2023.
William Tanner, Ph.D has served as the Company’s Chief Financial Officer since August 2023.
On August 14, 2023, the Company appointed Gerbrand van Heerden as the Chief Financial Officer of the Company, effective as of October 14, 2023.
On August 13, 2023, David Wiens resigned as the Chief Financial Officer of Bunker Hill Mining Corp. (the “ Company ”), effective as of October 14, 2023.
On August 16, 2023 (the “Transition Date”), Perry Del Vecchio resigned as the Chief Financial Officer of Alico, Inc. (the “Company”), effective immediately.
On the Transition Date, in connection with Mr. Del Vecchio’s resignation, the Company’s Board of Directors appointed Bradley Heine as the Company’s new Chief Financial Officer, effective immediately.
appointed Leonardo Basola as the Company’s Chief Financial Officer, effective September 5, 2023
who is resigning as Chief Financial Officer as previously disclosed
Also on August 15, 2023, the Company and John Taylor, the Company’s President, Chief Executive Officer, Chief Financial Officer and member of the Board, entered into that certain Executive Separation Agreement (the “Separation Agreement”), pursuant to which, in connection and contemporaneous with the Company’s entry into the Assignment Agreement and effectuation of the Assignment pursuant thereto, Mr. Taylor’s employment with the Company terminated.
the Board promoted Sassine Ghazi, Synopsys’ President and Chief Operating Officer, to the role of President and Chief Executive Officer
Tim Foufas, a long-time Board member, was appointed as Co-CEO and will serve as the Company's Principal Executive Officer, replacing Michael Ferrantino.
as Michael Ferrantino transitions from management to the Board.
On August 3, 2023, the Company and Jupiter Wellness entered into an Assignment and Assumption Agreement (the “McKinnon Assignment”), which became effective on August 14, 2023, to assume the employment agreement dated August 5, 2019, between Douglas McKinnon, Chief Financial Officer of the Company and former Chief Financial Officer of Jupiter Wellness, and Jupiter Wellness.
On August 15, 2023, TrueBlue, Inc. (the “Company”) announced that its current President and Chief Operating Officer, Taryn R. Owen, will become President and Chief Executive Officer of the Company, succeeding Steven C. Cooper, effective September 12, 2023.
On August 15, 2023, TrueBlue, Inc. (the “Company”) announced that its current President and Chief Operating Officer, Taryn R. Owen, will become President and Chief Executive Officer of the Company, succeeding Steven C. Cooper, effective September 12, 2023.
appointed Kenneth J. Zagzebski as Chairman of the Board and President and Chief Executive Officer of IPALCO and AES Indiana.
Effective September 30, 2023, Antonio Martino, Chief Financial Officer of the Company and the Bank, will depart from his role as Chief Financial Officer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.